🇺🇸 PEG-Lyte® in United States

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

PEG-Lyte® (PEG-Lyte®) regulatory status in United States.

Marketing authorisation

FDA

Application: ANDA073098
Marketing authorisation holder: SANDOZ
Local brand name: PEG-LYTE
Indication: FOR SUSPENSION — ORAL
Status: approved

Read official source →

Other Gastroenterology approved in United States

Frequently asked questions

Is PEG-Lyte® approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for PEG-Lyte® in United States?

SANDOZ holds the US marketing authorisation.